The MCS group (Medicinal Chemistry & Synthesis) has been accredited as a new TECNIO Center. This certification identifies it as an entity that offers the most innovative technologies to help companies create new products, processes or services.
This group focuses on chemical research to generate knowledge and therapeutic technologies, which combine the improvement and optimization of molecules of existing drugs and the definition of new therapeutic approaches. The MCS group, under the direction of Dr. Amadeu Llebaria, is formed by the Laboratory of Medicinal Chemistry (MedChemLab) and the Service of synthesis of high value added molecules (SIMChem), belonging to the Institute for Advanced Chemistry of Catalonia (IQAC).
The aim of the TECNIO certification, created by the Government of Catalonia, through ACCIÓ, is that Catalan companies identify where they can find new technologies for their needs for the development of new products and processes, through the acquisition or exploitation of patents, the recruitment of R+D+I projects or the contact with spin-offs.
More info: MCS group